Read More
Dexcom: Prospective investments in the healthcare sector
Dexcom, Inc. $DXCM, a well-known manufacturer of continuous glucose monitoring (CGM) devices, is gaining analyst attention for its growth potential despite recent challenges in the market. Analysts at BTIG, including Marie Thibault, view the current situation as a favorable entry point for investors.
Perfect find! As of the end of 2022, the company is hovering above the market consensus on earnings and their numbers are still rising. The outlook is for this to continue to hold through at least 2027. Absolutely brilliant. Even debt and margins, which are rising. The company is a bit more expensive now, but it could maybe start paying a dividend :)